538 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
SNY Sanofi $43.75 $109.14B N/A
Article Searches
4 Senior Executives Are Leaving Sanofi Following New CEO's Strategic Overhaul https://www.fool.com/investing/2020/02/11/4-senior-executives-are-leaving-sanofi-following-n.aspx?source=iedfolrf0000001 Feb 11, 2020 - Big changes are on the horizon for this pharmaceutical giant.
Regeneron Reports Positive Eylea Data From Late-Stage Study http://www.zacks.com/stock/news/758360/regeneron-reports-positive-eylea-data-from-late-stage-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-758360 Feb 10, 2020 - Regeneron (REGN) announces positive two-year results from the phase III PANORAMA study on lead ophthalmology drug, Eylea.
Pharma Stock Roundup: BMY, GSK, SNY Q4 Results, MRK Earnings & Split http://www.zacks.com/stock/news/754444/pharma-stock-roundup-bmy-gsk-sny-q4-results-mrk-earnings-split?cid=CS-ZC-FT-analyst_blog|stock_roundup-754444 Feb 07, 2020 - Merck (MRK), Bristol Myers (BMY), Sanofi (SNY), Glaxo (GSK) and Novo Nordisk (NVO) announce Q4 results.
Alnylam's (ALNY) Q4 Earnings Miss Estimates, Sales Beat http://www.zacks.com/stock/news/754291/alnylams-alny-q4-earnings-miss-estimates-sales-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-754291 Feb 07, 2020 - Alnylam (ALNY) posts a wider-than-expected loss, while revenues beat estimates marginally in the fourth quarter of 2019.
Sanofi (SNY) CEO Paul Hudson on Q4 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4322316-sanofi-sny-ceo-paul-hudson-on-q4-2019-results-earnings-call-transcript?source=feed_sector_healthcare Feb 07, 2020 - Sanofi (NASDAQ:SNY) Q4 2019 Results Earnings Conference Call February 06, 2020, 9:00 am ET Company Participants Felix Lauscher - Head of Investor Relations North America and Asia Paul Hudson - Chief E
Sanofi (SNY) Q4 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2020/02/07/sanofi-sny-q4-2019-earnings-call-transcript.aspx?source=iedfolrf0000001 Feb 07, 2020 - SNY earnings call for the period ending December 31, 2019.
Sanofi Grows Revenue by 6.8% in Fourth Quarter Boosted by Dupixent https://www.fool.com/investing/2020/02/06/sanofi-grows-revenue-by-68-in-fourth-quarter-boost.aspx?source=iedfolrf0000001 Feb 06, 2020 - Sometimes slow and steady wins the race.
Sanofi (SNY) Q4 Earnings Top, Sales Miss, Dupixent Strong http://www.zacks.com/stock/news/752611/sanofi-sny-q4-earnings-top-sales-miss-dupixent-strong?cid=CS-ZC-FT-analyst_blog|earnings_article-752611 Feb 06, 2020 - Sanofi (SNY) reports mixed fourth-quarter results with strong Specialty Care and Vaccines sales but soft Consumer Healthcare sales
Why Earnings Season Could Be Great for Sanofi (SNY) http://www.zacks.com/stock/news/750537/why-earnings-season-could-be-great-for-sanofi-sny?cid=CS-ZC-FT-tale_of_the_tape|earnings_surprise-750537 Feb 05, 2020 - Sanofi (SNY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Novo Nordisk (NVO) Q4 Earnings Match Estimates, Revenues Beat http://www.zacks.com/stock/news/750701/novo-nordisk-nvo-q4-earnings-match-estimates-revenues-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-750701 Feb 05, 2020 - Novo Nordisk (NVO) posts in-line earnings, while revenues beat estimates in the fourth quarter of 2019.

Pages: 1234567...54

<Page 2>